Sign Up Today and Learn More About PsiQuantum Stock

Invest in or calculate the value of your shares in PsiQuantum or other pre-IPO companies through EquityZen's platform.

Get Started

PsiQuantum Stock

PsiQuantum leverages silicon photonics, a mature technology, to build fault-tolerant quantum computers. They claim this avoids the complexities of exotic materials, capitalizing on decades of established silicon chip manufacturing to deliver a scalable path to the future of computing.

PsiQuantum focuses on building a large-scale, general-purpose silicon photonic quantum computer with at least 1 million physical qubits.

About PsiQuantum Stock




Palo Alto, CA, US

Notable Investor


Total Funding


PsiQuantum is developing a quantum computer using silicon photonics technology. In contrast to a matter-based quantum computing approach, PsiQuantum claims they benefit from over 50 years of research and trillions of dollars invested in silicon wafer technology. PsiQuantum aims to utilize photonic qubits in their computing solutions, and as such, don't need to develop novel quantum technologies to create qubits from solid matter as their competitors do.

PsiQuantum was founded in 2016 and is headquartered in Palo Alto, California. Notable investors include BlackRock, Baillie Gifford, and Microsoft.

Investors in PsiQuantum

Discover investors in PsiQuantum stock and explore their portfolio companies

PsiQuantum Management

Leadership team at PsiQuantum

Co-founder and CEO

Jeremy O'Brien

Co-founder and Chief Strategy Officer

Peter Shadbolt

Locked Features

Join now and verify your accreditation status to gain access to:

  • PsiQuantum current valuation
  • PsiQuantum stock price
  • Available deals in PsiQuantum and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in PsiQuantum stock?

Accredited investors can buy pre-IPO stock in companies like PsiQuantum through EquityZen funds. These investments are made available by existing PsiQuantum shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell PsiQuantum stock?

Shareholders can sell their PsiQuantum stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."